Accelerating cures for cancer by integrating discoveries in biology with innovative technology

The Mark Foundation for Cancer Research funds groundbreaking science across all cancer types through grants to individual investigators and multi-disciplinary teams, as well as venture investment in early-stage companies. Here’s a snapshot of our portfolio since our founding in 2017.

SINCE 2017

146 Research Grants

Over $125 Million Awarded


          • 23% Basic Research
          • 2% Clinical Research
          • 18% Technology Innovation
          • 10% Therapeutic Discovery
          • 47% Translational Science

          SINCE 2017

          Investments in 6 Companies

          Over $20 Million Invested


                  • 32.3% Diagnostics
                  • 18.1% Cell & Gene Therapy
                  • 19.9% Small Molecule Therapy
                  • 29.8% Biologics

                  latest news


                  Research Spotlight: Alessandro Leal, and Jillian Phallen.

                  Read More

                  The Mark Foundation for Cancer Research funds Jackson Laboratory scientists

                  Read More

                  Research Spotlight: Shin Foong Ngiow

                  Read More

                  Spotlight on Critical Issues in Cancer Research: Metastasis

                  Read More

                  A Note on COVID-19/Novel Coronavirus

                  Read More